A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Recruiting

mRNA-1283 & mRNA-1273A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Sponsor:

Moderna

Code:

NCT07266558

Conditions

SARS-CoV-2

Eligibility Criteria

Sex: All

Age: 50 - 64

Healthy Volunteers: Accepted

Interventions

mRNA-1273

mRNA-1283

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-29. This information was provided to ClinicalTrials.gov by ModernaTX, Inc. on 2025-12-15.